AM:EURONEXT PARISDassault Aviation SA Analysis
Data as of 2026-09-01 - not real-time
$22.42
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Antero Midstream Corporation trades at $22.42, with its moving averages tangled rather than clearly stacked — a neutral trend structure. With RSI at 53.1 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $21.11 and resistance around $22.90.
Valuation screens as fair: a P/E of 27.0 sits above the sector average of 21.6. The average analyst target implies 8.3% above today's level. Revenue is growing at 8.3% on a 30.4% profit margin. The 4.04% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 25.3%, a beta of -0.08 and a maximum drawdown of 12.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
Valuation screens as fair: a P/E of 27.0 sits above the sector average of 21.6. The average analyst target implies 8.3% above today's level. Revenue is growing at 8.3% on a 30.4% profit margin. The 4.04% dividend yield looks stretched against payout coverage.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 25.3%, a beta of -0.08 and a maximum drawdown of 12.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 3/10 conviction on the long call.
Top Market Events
Updated Jul 15, 2026 0 DENVER, July 15, 2026 /PRNewswire/ -- Antero Midstream Corporation NYSE: AM "Antero Midstream"...Antero Midstream Announces Second Quarter 2026 Financial and Operating Results PR Newswire DENVER, July 29, 2026...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 20.84
- MACD momentum is positive
- RSI at 53.1 is in neutral territory
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.0 versus sector average of 21.6
- Dividend yield of 4.04% looks stretched against payout coverage
- Trading above the 200-day average of 20.84
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.0 versus sector average of 21.6
- Dividend yield of 4.04% looks stretched against payout coverage
- Analyst targets imply +8.3% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin30.45%
P/E Ratio27.0
ROE19.82%
ROA7.61%
Debt/Equity185.54
P/B Ratio5.5
Op. Cash Flow$961.2M
Free Cash Flow$432.6M
Industry P/E21.6
Technical Analysis
TrendNeutral
RSI53.1
Support$21.11
Resistance$22.90
MA 20$22.10
MA 50$22.28
MA 200$20.84
MACDBullish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$8.88
Target Price$24.29
Upside/Downside8.32%
GradeFair
TypeBlend
Dividend Yield4.04%
Risk Assessment
Beta-0.08
Volatility25.33%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.